Latest Morning Briefing Stories
Legal Questions, Inquiries Intensify Around Noble Health’s Rural Missouri Hospital Closures
A year after private equity-backed Noble Health shuttered two rural Missouri hospitals, a slew of lawsuits and state and federal investigations grind forward. Missouri Attorney General Andrew Bailey recently confirmed an “ongoing” investigation as former employees continue to go unpaid and cope with unpaid medical claims.
California Picks Generic Drug Company Civica to Produce Low-Cost Insulin
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He’s also eyeing other generic drugs.
California eligió a la compañía de genéricos Civica para producir insulina de bajo costo
Civica está desarrollando tres tipos de insulina genérica, conocida como biosimilar, que estarán disponibles tanto en viales como en plumas inyectables, a un costo de entre $30 y $55.
Journalists Discuss Medicaid Unwinding and Clawbacks
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Temp Nurses Cost Hospitals Big During Pandemic. Lawmakers Are Now Mulling Limits.
Missouri is considering making it a felony to jack up temporary health care staffing prices during a statewide or national emergency. It’s one of at least 14 states looking to reel in travel nurse costs, after many hospitals struggled to pay for needed staffers earlier in the covid pandemic.
Listen to ‘Tradeoffs’: Medical Debt Delivers ‘A Shocking Amount of Misery’
Medical debt in America pushes families to the edge. Ariane Buck and his wife, Samantha, were denied care at their doctor’s office because of an unpaid bill of less than $100. A trip to the emergency room added thousands of dollars to their health care debt, which topped $50,000 by the time they filed for bankruptcy.
Two Counties Square Off With California Over Mental Health Duties
The state wants to stop paying Kaiser Permanente for treating severely mentally ill Medi-Cal patients in Sacramento and Solano counties and force the counties to take on the task. The counties’ leaders say they can’t afford it.
An Arm and a Leg: Wrestling With a Giant: How to Dispute a Hospital Bill
One listener tried to dispute a $1,300 “facility fee” with the treating hospital, his insurer, a bill-mediation service provided by his employer, and finally a debt collector. He didn’t win, but he learned valuable lessons about advocating for hospital discounts.
KFF Health News' 'What the Health?': Biden Budget Touches All the Bases
Very little in the proposed budget released by the Biden administration is likely to become law, particularly with Republicans in charge of the U.S. House. Still, the document is an important statement of the president’s policy priorities, and it’s clear health programs are among those he feels are important. Meanwhile, five women who were denied abortions when their pregnancies threatened their lives are suing Texas. Shefali Luthra of The 19th, Victoria Knight of Axios, and Margot Sanger-Katz of The New York Times join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Harris Meyer, who reported and wrote the two latest KHN-NPR “Bill of the Month” features. Both were about families facing unexpected bills following childbirth.
Planes de salud de Medicaid intentan proteger a sus miembros… y a sus ganancias
Estos planes, muchos administrados por titanes de los seguros, incluidos UnitedHealthcare, Centene y Aetna, han visto aumentar sus ingresos en miles de millones a medida que su membresía aumentaba en millones.
A los pocos meses de usar AGGA, una paciente dijo que sus dientes estaban tan flojos que podía sentir cómo se movían cuando se untaba crema hidratante en las mejillas. Besar a su novio le resultaba incómodo.
La insulina representa lo perverso del sistema sanitario estadounidense, ya que los precios de venta de este medicamento centenario, del que dependen 8,4 millones de estadounidenses para sobrevivir, se quintuplicaron en dos décadas.
Medicaid Health Plans Try to Protect Members — And Profits — During Unwinding
States are turning to the big health insurance companies to keep Medicaid enrollees insured once pandemic protections end in April. The insurers’ motive: profits.
Why Does Insulin Cost So Much? Big Pharma Isn’t the Only Player Driving Prices
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but it’s the arbitrators that jack up prices for those who can least afford them.
Watch: Emergency Room Turns Simple Injury Into a Big Bill
This installment of InvestigateTV and KHN’s “Costly Care” series looks at the case of a New Orleans woman whose thumb injury saddled her with a big ER bill for a tetanus shot and some minor care.
For Young People on Medicare, a Hysterectomy Sometimes Is More Affordable Than Birth Control
While Medicare was designed as health insurance for those 65 and older, it also covers people with disabilities who are young enough to still get pregnant. Yet they often struggle to get their birth control covered and end up with large medical bills — or instead opt for hysterectomies or tubal ligations, which Medicare sometimes will cover.
Biden Administration Urged to Take More Aggressive Steps to Relieve Medical Debt
Consumer and patient advocates push for new federal rules to protect Americans from debt collectors and force hospitals to make financial assistance more accessible.
Hospitales rurales aplican a nuevo programa federal para intentar sobrevivir
Más de 140 hospitales rurales han cerrado en todo el país desde 2010, y observadores de políticas de salud no están seguros de cuántas de las más de 1,700 instalaciones rurales elegibles para la nueva designación aplicarán a un nuevo programa.
Journalists Discuss Insulin Prices, Gun Violence, Distracted Driving, and More
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Decisión de Eli Lilly de bajar el precio de su insulina logrará cambios históricos en los costos
Expertos en precios de medicamentos celebraron la noticia de Eli Lilly y otros esfuerzos. Y estas otras iniciativas para llevar al mercado insulina de menor costo, a su vez, presionarían a Eli Lilly para que mantuviera sus precios bajos.
